Delivery Order SPE2DB22D3501-SPE2DB25FVZ13
Award Date
6/9/25
Potential Completion Date
6/10/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,681.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RAMELTEON 8 MG TABLET 30S, a prescription medication, with a period of performance through March 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,478.04 fixed-price delivery order is for the supply of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product, with a completion date of July 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,077.38, is for the supply of RAMELTEON 8 MG TABLET 30S, a medication used to treat insomnia. The contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,508.63 firm fixed-price delivery order is for the supply of RAMELTEON 8 MG TABLET 30S, a medication used to treat insomnia. The award is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,430.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ramelteon 8 mg tablets, a sleep medication, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,212.24 firm fixed-price delivery order is for the supply of Ramelteon 8 MG Tablet UD 50S, a medication used to treat insomnia. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is an order for the pharmaceutical drug Ramelteon 8 mg tablet, valued at $24,179.29, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a firm fixed price and a completion date of May 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a comprehensive range of medical products and supplies to various federal agencies, particularly in support of military and veterans'...
The Department of Defense's Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 50 units of the pharmaceutical RAMELTEON 8 MG TABLET UD. The $1,999.20 contract has a performance period ending January 11, 2024. AmerisourceBergen Drug Corp, which provides pharmaceutical products and services to U.S. government agencies, including the Department of Defense, has received numerous federal...
This is a Delivery Order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) with a Ceiling Value of $1,723.77. The contract is for the provision of Ramelteon 8 mg Tablets in quantities of 100s. The contract has a period of performance through June 28, 2024 and is a Firm Fixed Price contract. No set-aside designation was used for this award. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a...
This federal contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply a range of medical products including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across...